NCT03911960

Brief Summary

People with serious mental illness are three times more likely to smoke cigarettes than people without mental illness. People with mental illness are less likely to be successful in quitting smoking than those without mental illness. Therefore, the healthcare community needs to find ways to get people with mental illness treatment to help them stop smoking. This study explores whether a treatment, called acceptance and commitment therapy, which is an affective therapy for serious mental illness, can help patients with serious mental illness stop smoking. In particular, the investigators test whether patients will be interested in receiving acceptance and commitment therapy for smoking cessation in a psychiatric partial hospital (also known as a day treatment program), whether they are able to complete the treatment, and whether it will help them stop smoking compared to usual care. To test these research questions, 40 patients in the Rhode Island Hospital's psychiatric partial hospital will be recruited. Half of the patients will receive acceptance and commitment therapy to help them stop smoking (2 in person sessions, 5 telephone sessions) and half will receive usual care (2 in person sessions, electronic referral to the Rhode Island tobacco quit line). All participants will be offered the nicotine patch. All participants will complete a baseline survey and a follow-up visit at the end of treatment to measure whether they stopped smoking and whether they liked the treatment. The study will also measure how many participants completed the treatment sessions. If successful, this treatment model could be a way to get more patients with mental illness into treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

April 16, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2019

Completed
11 months until next milestone

Results Posted

Study results publicly available

September 25, 2020

Completed
Last Updated

September 25, 2020

Status Verified

January 1, 2019

Enrollment Period

7 months

First QC Date

March 26, 2019

Results QC Date

September 1, 2020

Last Update Submit

September 23, 2020

Conditions

Keywords

tobacco smokingpsychiatric disorderpsychiatric hospitalizationacceptance and commitment therapy

Outcome Measures

Primary Outcomes (4)

  • Feasibility of Recruitment: Proportion of Smokers Seen During the Partial Hospital Visit Who Enroll in the Study

    proportion of smokers seen during the partial hospital visit who enroll in the study

    Through study completion, approximately 5 months.

  • Percentage of Counseling Sessions Completed

    number of scheduled counseling sessions completed

    through study completion, an average of 7 weeks.

  • Client Satisfaction Questionnaire

    The Client satisfaction Questionnaire, measures acceptability of the intervention to patients, minimum value=8, maximum value=32, higher scores indicate higher satisfaction (higher scores mean better outcome)

    at study completion, an average of 7 weeks post-enrollment

  • Number of Participants Who Are Rehospitalized for Psychiatric Reasons

    This is a simple count based on follow-up survey data of the number of participants who reported being hospitalized for a psychiatric reason following enrollment in the study.

    At study completion, an average of 7 weeks post enrollment

Secondary Outcomes (2)

  • Number of Participants Who Are Abstinent From Tobacco

    at study completion, an average of 7 weeks post enrollment

  • Kessler 6

    Change between baseline and study completion, 7 weeks post-enrollment

Other Outcomes (2)

  • Avoidance Inflexibility Scale

    Change between baseline and study completion, 7 weeks post-enrollment

  • Commitment to Quitting Scale

    Change between baseline and study completion, 7 weeks post-enrollment

Study Arms (2)

Acceptance and Commitment Therapy

EXPERIMENTAL

2 in person and 5 telephone sessions of Acceptance and Commitment Therapy for tobacco cessation plus up to 8 weeks of nicotine patch.

Behavioral: Acceptance and Commitment Therapy

Enhanced Usual Care

ACTIVE COMPARATOR

2 in-person sessions of tobacco cessation counseling, electronic referral to state quitline, up to 8 weeks of nicotine patch

Behavioral: Enhanced Usual Care

Interventions

2 in person and 5 telephone sessions of acceptance and commitment therapy for tobacco cessation plus up to 8 weeks of nicotine patch

Acceptance and Commitment Therapy

2 in person sessions of tobacco cessation counseling, up to 8 weeks of nicotine patch, referral to state quitline.

Enhanced Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be male and female
  • psychiatry partial hospital patients
  • current daily smokers
  • ≥ age 18
  • have regular telephone access
  • able to read and write English

You may not qualify if:

  • current use of tobacco cessation treatment (bupropion prescribed for a psychiatric indication will be permitted)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Miriam Hospital

Providence, Rhode Island, 02906, United States

Location

MeSH Terms

Conditions

Tobacco SmokingMental Disorders

Interventions

Acceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

SmokingBehaviorTobacco Use

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Sandra Japuntich
Organization
Hennepin Healthcare

Study Officials

  • Sandra Japuntich, Ph.D.

    Hennepin Healthcare Research Institute

    PRINCIPAL INVESTIGATOR
  • Ernestine Jennings, Ph.D.

    The Miriam Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2019

First Posted

April 11, 2019

Study Start

April 16, 2019

Primary Completion

November 15, 2019

Study Completion

November 15, 2019

Last Updated

September 25, 2020

Results First Posted

September 25, 2020

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will share

Only the Principal Investigator will give permission for the release of aggregated study data. No identifiable data will be released. Participants in the proposed research will be informed, during consent, that completely de-identified data (i.e., data that has been cleaned of all 18 types of HIPAA identifiers) will be available to other qualified researchers. Within 18 months of study completion, we will make datasets available to interested investigators who submit a written request to the PI. The only contingency on the use of the data will be that ethical guidelines be followed (e.g., only individuals who have completed a research ethics training course will have access to the data, the data will be stored securely). The NIH will be notified of transmissions of the data to interested investigators.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
within 18 months of study completion
Access Criteria
ethical guidelines for The Miriam Hospital will be followed (the investigator will have completed a research ethics training course and the data will be stored securely)

Locations